New Genetic Analysis Reveals Autism-Linked Syndrome is Underdiagnosed

New analysis indicates Phelan-McDermid syndrome, a genetic disorder often associated with autism spectrum disorder, could be considerably more common than previous estimates. Researchers now believe the condition may affect approximately 1 in 7,300 people, translating to over 45,000 Americans potentially living with the syndrome.

The diagnostic gap

The discrepancy stems from under-diagnosis. Historically considered a rare disease, Phelan-McDermid syndrome often goes undetected because genetic testing isn't routinely performed for individuals presenting with its symptoms, which can include developmental delay, intellectual disability, and challenges with communication. This situation persists even as targeted therapies move into clinical trials, creating a widening gap between those who could benefit from intervention and those who receive a diagnosis.

The findings, rooted in a major re-analysis of genetic data, highlight a common issue in medical diagnostics where conditions are deemed 'rare' simply because they are rarely looked for. This reclassification has significant implications for patient advocacy, research funding, and the development of support services. Earlier, more accurate diagnosis can lead to earlier interventions, potentially mitigating some of the syndrome's more challenging aspects.

For individuals and families navigating complex health landscapes, this news reinforces the importance of persistent advocacy for comprehensive diagnostic evaluations. Understanding the true prevalence of such conditions allows for better resource allocation and tailored care, ensuring that more people receive the support and treatment they need.